comparemela.com
Home
Live Updates
David Liberg - Breaking News
Pages:
Latest Breaking News On - David liberg - Page 1 : comparemela.com
Cantargia AB: Cantargia to host R&D Day on new clinical results of nadunolimab in pancreatic cancer on April 24, 2023
LUND, Sweden, April 4, 2023 /PRNewswire/ Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced it will host an R&D Day focusing on new clinical results and biomarker data for
Region flamande
David liberg
Van cutsem
Dominique tersago
Eric van cutsem
Prnewswire cantargia
University hospitals gasthuisberg
Vp research
University of warsaw
Belgian foundation
Nasdaq stockholm
Division head
Digestive oncology
Eric van
Medical university
Prof van cutsem
Cantargia to host R&D Day on new clinical results of nadunolimab in pancreatic cancer on April 24, 2023
LUND, Sweden, April 4, 2023 /PRNewswire/ Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today.
Region flamande
Van cutsem
Eric van cutsem
Phderic van cutsem
Dominique tersago
David liberg
Prnewswire cantargia
University hospitals gasthuisberg
Vp research
Belgian foundation
University of warsaw
Nasdaq stockholm
Division head
Digestive oncology
Eric van
Medical university
vimarsana © 2020. All Rights Reserved.